"10.1371_journal.ppat.1000116","plos pathogens","2008-08-01T00:00:00Z","Victoria Rydeng√•rd; Oonagh Shannon; Katarina Lundqvist; Lukasz Kacprzyk; Anna Chalupka; Anna-Karin Olsson; Matthias M√∂rgelin; Willi Jahnen-Dechent; Martin Malmsten; Artur Schmidtchen","Section of Dermatology and Venereology, Department of Clinical Sciences, Lund University, Biomedical Center, Lund, Sweden; Section of Infection Medicine, Department of Clinical Sciences, Lund University, Biomedical Center, Lund, Sweden; Department of Microbiology, Faculty of Biochemistry, Biophysics & Biotechnology, Jagiellonian University, Krak√≥w, Poland; Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala Biomedical Center, Uppsala, Sweden; Department of Biomedical Engineering, RWTH Aachen University Hospital, Aachen, Germany; Department of Pharmacy, Uppsala University, Uppsala Biomedical Center, Uppsala, Sweden","Conceived and designed the experiments: V. Rydeng√•rd, O. Shannon, M. M√∂rgelin, M. Malmsten, A. Schmidtchen. Performed the experiments: V. Rydeng√•rd, O. Shannon, K. Lundqvist, L. Kacprzyk, A. Chalupka, A. Olsson, M. M√∂rgelin, M. Malmsten. Analyzed the data: V. Rydeng√•rd. Contributed reagents/materials/analysis tools: W. Jahnen-Dechent. Wrote the paper: V. Rydeng√•rd, A. Schmidtchen. Critically read the manuscript: W. Jahnen-Dechent. All authors critically revised the manuscript.","Drs. Schmidtchen and Malmsten have shares in DermaGen AB, a company involved in therapeutical development of antimicrobial peptides. Peptides of HRG are included in patent applications of the company.","2008","08","Victoria Rydeng√•rd","VR√",10,TRUE,1,1,1,1,TRUE,TRUE,TRUE,8,"2;3;4;5;6;7;9;10",TRUE
